|
|
| (11 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| | + | {{ft|X}} |
| | *'''[[Diagnosis (Laboratory other parameters)]]''' | | *'''[[Diagnosis (Laboratory other parameters)]]''' |
| | + | *'''[[Dx multi-virus]]''' |
| | *'''[[Dx PCR]]''' | | *'''[[Dx PCR]]''' |
| | *'''[[Dx Antigen]]''' | | *'''[[Dx Antigen]]''' |
| Zeile 9: |
Zeile 11: |
| | *'''[[Dx which matrix]]''' how to obtain, which to use | | *'''[[Dx which matrix]]''' how to obtain, which to use |
| | | | |
| − | | + | ---- |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32077933|t=ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32154877|t=ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32353116|t=ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32315390|t=ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform |pdf=|usr=}}
| + | |
| − | {{tp|p=32282874|t=ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2) |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32229107|t=2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient |pdf=|usr=}}
| + | |
| − | {{tp|p=32031583|t=ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32156607|t=ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32335089|t=ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32358960|t=ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32306042|t=ä. Testing for SARS-CoV-2: Can We Stop at Two?|pdf=|usr=}}
| + | |
| − | {{tp|p=32276116|t=ä. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay |pdf=|usr=}}
| + | |
| − | {{tp|p=32306036|t=ä. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32197339|t=2020. Point-of-Care RNA-Based Diagnostic Device for COVID-19 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32294051|t=2020. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32306853|t=2020. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32102625|t=2020. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32329811|t=2020. The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-nCov |pdf=|usr=}}
| + | |
| − | {{tp|p=32156329|t=2020. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system |pdf=|usr=}}
| + | |
| − | {{tp|p=31992387|t=2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32290902|t=2020. An alternative workflow for molecular detection of SARS-CoV-2 escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32290904|t=2020. Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32156101|t=2020. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32297805|t=2020. Real-time RT-PCR in COVID-19 detection: issues affecting the results |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32242876|t=2020. Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32370065|t=2020. Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
| + | |
| − | {{tp|p=32344568|t=2020. RT-qPCR Testing of SARS-CoV-2: A Primer |pdf=|usr=}}
| + | |
| − | {{tp|p=32276333|t=2020. Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32325642|t=2020. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32341142|t=2020. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32132196|t=2020. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32361322|t=2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus |pdf=|usr=}}
| + | |
| − | {{tp|p=32361324|t=ä. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study |pdf=|usr=}}
| + | |
| − | {{tp|p=32302956|t=2020. Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32360885|t=ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32276051|t=ä. Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32292623|t=2020. Recent advances and perspectives of nucleic acid detection for coronavirus |pdf=|usr=}}
| + | |
| − | {{tp|p=32352933|t=2020. Characteristics and diagnosis rate of 5630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32074516|t=2020. Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan |pdf=|usr=}}
| + | |
| − | {{tp|p=32350226|t=2020. An assessment of real-time RT-PCR kits for SARS-CoV-2 detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32266524|t=ä. A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT |pdf=|usr=}}
| + | |
| − | {{tp|p=32207257|t=2020. A Patient with COVID-19 Presenting a False-Negative Reverse Transcriptase Polymerase Chain Reaction Result |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{ttp|p=32224308|t=ä. Understanding COVID-19: what does viral RNA load really mean?|pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32217609|t=2020. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS?CoV-2/COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32361529|t=ä. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32333644|t=2020. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32074444|t=2020. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{ttp|p=32358057|t=2020. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32327566|t=2020. One ventilator for two patients: feasibility and considerations of a last resort solution in case of equipment shortage |pdf=|usr=}}
| + | |
| − | {{tp|p=32378843|t=2020. Akutt lungesviktsyndrom hos covid-19-pasient med negative nasofarynksprover |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32283215|t=ä. False negative rate of COVID-19 is eliminated by using nasal swab test |pdf=|usr=}}
| + | |
| − | {{tp|p=32239445|t=ä. Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{ttp|p=32293905|t=2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32338536|t=2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR) |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{ttp|p=32221132|t=2020. In Silico assessment of the impact of 2019 novel coronavirus (2019-nCoV) genomic variation on published real-time quantitative polymerase chain reaction detection assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32149771|t=2020. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32242829|t=2020. One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{ttp|p=32311826|t=2020. COVID-19 and the clinical hematology laboratory |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32222993|t=ä. Genomic characterization and phylogenetic analysis of SARS?COV?2 in Italy |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32096564|t=ä. Combination of RT?qPCR testing and clinical features for diagnosis of COVID?19 facilitates management of SARS?CoV?2 outbreak |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32270882|t=2020. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32271278|t=2020. Integrated Radiologic Algorithm for COVID-19 Pandemic |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32334422|t=2020. Smartphone-based multiplex 30-minute nucleic acid test of live virus from nasal swab extract |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32223871|t=2020. Preliminary Results of Initial Testing for Coronavirus (COVID-19) in the Emergency Department |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32387093|t=2020. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32378133|t=ä. Initial Observations with Molecular Testing for COVID-19 in a Private Hospital in Mumbai, India |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32416598|t=2020. SARS-CoV-2 detection by direct rRT-PCR without RNA extraction |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32388470|t=2020. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa? COVID-19 direct assay |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32403009|t=2020. Five-minute point-of-care testing for SARS-CoV-2: Not there yet |pdf=|usr=}}
| + | |
| − | {{tp|p=32403008|t=2020. A RT-PCR assay for the detection of coronaviruses from four genera |pdf=|usr=}}
| + | |
| − | {{tp|p=32388472|t=2020. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32388471|t=2020. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32006218|t=ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32248474|t=2020. Vergessen Sie die Schnellteste auf Coronavirus!|pdf=|usr=}}
| + | |
| − | {{tp|p=32342388|t=2020. Anwendung von Antikörper-Schnelltests ist Körperverletzung: Dr Matthias Orth |pdf=|usr=}}
| + | |
| − | {{tp|p=32372836|t=2020. The problems with so-called immunity tests |pdf=|usr=}}
| + | |
| − | {{tp|p=32376476|t=ä. Limited effectiveness of systematic screening by nasopharyngeal RT-PCR of medicalized nursing home staff after a first case of COVID-19 in a resident |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32149770|t=2020. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32396505|t=2020. US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32448084|t=2020. Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32438868|t=2020. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32505692|t=2020. Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32492531|t=2020. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | {{tp|p=32505778|t=2020. Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32512376|t=2020. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32459081|t=2020. Evaluacion de diferentes genes en la deteccion por RT-PCR del SARS-CoV-2 en muestras respiratorias y su evolucion en la infeccion.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32329388|t=2020. Positive RT-PCR test results after consecutively negative results in patients with COVID-19.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32474555|t=2020. Evaluation of RdRp & ORF-1b-nsp14-based real-time RT-PCR assays for confirmation of SARS-CoV-2 infection: An observational study.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | {{tp|p=32423519|t=2020. Screening for COVID-19: Patient Factors Predicting Positive PCR Test.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | {{tp|p=32449639|t=2020. SARS-CoV-2 RT-PCR: at least 2 viral targets are needed.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32420777|t=2020. Positive RT-PCR in urine from an asymptomatic patient with novel coronavirus 2019 infection: a case report.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32501535|t=2020. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32484950|t=2020. Amplification of human beta-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32475012|t=2020. Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | {{tp|p=32506118|t=2020. Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32504529|t=2020. Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity?|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32472672|t=2020. What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients?|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32435816|t=2020. To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32320539|t=2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32401598|t=2020. COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?|pdf=|usr=007}}
| + | |
| − | {{tp|p=32401535|t=2020. Reply to: COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32270938|t=2020. Performance du frottis nasopharynge-PCR pour le diagnostic du Covid-19 - Recommandations pratiques sur la base des premieres donnees scientifiques.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32483586|t=2020. Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32461287|t=2020. Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV RT-PCR assay for the detection of SARS-CoV-2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32461285|t=2020. Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32444354|t=2020. Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32381643|t=2020. Comparison of Two High-Throughput Reverse Transcription-Polymerase Chain Reaction Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32381642|t=2020. Understanding, verifying and implementing Emergency Use Authorization molecular diagnostics for the detection of SARS-CoV-2 RNA.|pdf=|usr=007}}
| + | |
| − | {{tp|p=32471894|t=2020. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution.|pdf=|usr=007}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | ===008===
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32469511|t=2020. Virus Detection: What Were We Doing before COVID-19 Changed the World?|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32528710|t=2020. Persistence of positive severe acute respiratory syndrome coronavirus-2 reverse transcription-polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32438806|t=2020. Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32395391|t=2020. Development of a rapid test kit for SARS-CoV-2: an example of product design.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32387502|t=2020. Reduced Physical Activity During COVID-19 Pandemic in Children With Congenital Heart Disease.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32427226|t=2020. An automated Residual Exemplar Local Binary Pattern and iterative ReliefF based corona detection method using lung X-ray image.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32384153|t=2020. Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (exo-IQ).|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32422410|t=2020. Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32502646|t=2020. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital.|pdf=|usr=008
| + | |
| − | | + | |
| − | {{tp|p=32444479|t=2020. Incidental COVID-19 on PET/CT imaging.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32530490|t=2020. A Simple Method for Detection of a Novel Coronavirus (SARS-CoV-2) using One-step RT-PCR followed by Restriction Fragment Length Polymorphism.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32441935|t=2020. A Reverse-Transcription Recombinase-Aided Amplification Assay for Rapid Detection of the 2019 Novel Coronavirus (SARS-CoV-2).|pdf=|usr=008}}
| + | |
| − | {{tp|p=32490854|t=2020. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32515793|t=2020. Why, when, and how to use lung ultrasound during the COVID-19 pandemic: enthusiasm and caution.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32527161|t=2020. How Fear Appeal Approaches in COVID-19 Health Communication May Be Harming the Global Community.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32533803|t=2020. The Covid-19 'infodemic': a new front for information professionals.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32522311|t=2020. RT-PCR tests for SARS-CoV-2 processed at a large Italian Hospital and false-negative results among confirmed COVID-19 cases.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32530790|t=2020. Ellen Grass Lecture: Wellness for Allied Healthcare Professionals in the Age of COVID-19.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32489177|t=2020. Authors' response: SARS-CoV-2 detection by real-time RT-PCR.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32489175|t=2020. Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32452225|t=2020. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32535302|t=2020. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32531884|t=2020. The Enemy Which Sealed the World: Effects of COVID-19 Diffusion on the Psychological State of the Italian Population.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32098019|t=2020. Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19).|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32281158|t=2020. The pandemic paradox: The consequences of COVID-19 on domestic violence.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32344460|t=2020. The potential for COVID-19 to contribute to compassion fatigue in critical care nurses.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32320509|t=2020. Covid-19: Supporting nurses' psychological and mental health.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32535398|t=2020. Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32504943|t=2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32535397|t=2020. Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32344319|t=2020. Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32485473|t=2020. Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studies.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32474371|t=2020. Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32460173|t=2020. Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32416600|t=2020. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32405254|t=2020. Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32446722|t=2020. Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection.|pdf=|usr=008}}
| + | |
| − | {{ttp|p=32173458|t=2020. Experience of different upper respiratory tract sampling strategies for detection of COVID-19.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32473233|t=2020. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.|pdf=|usr=008}}
| + | |
| − | {{tp|p=32473229|t=2020. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32383182|t=2020. Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?|pdf=|usr=008}}
| + | |
| − | {{tp|p=32383179|t=2020. Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR test.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | {{tp|p=32401374|t=2020. Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test.|pdf=|usr=008}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | {{tp|p=32496708|t=2020. COVID-19 : quelle place, aujourd'hui, pour les tests serologiques ?|pdf=|usr=008}}
| + | |
| − | {{tp|p=32536002|t=2020. Pitfalls in SARS-CoV-2 PCR diagnostics.|pdf=|usr=008}}
| + | |
